首页> 美国卫生研究院文献>BioMed Research International >A Metabolomic Study on the Intervention of Traditional Chinese Medicine Qushi Huayu Decoction on Rat Model of Fatty Liver Induced by High-Fat Diet
【2h】

A Metabolomic Study on the Intervention of Traditional Chinese Medicine Qushi Huayu Decoction on Rat Model of Fatty Liver Induced by High-Fat Diet

机译:中药祛湿化瘀汤干预高脂饮食诱导的脂肪肝大鼠的代谢组学研究

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Qushi Huayu Decoction (QHD), an important clinically proved herbal formula, has been reported to be effective in treating fatty liver induced by high-fat diet in rats. However, the mechanism of action has not been clarified at the metabolic level. In this study, a urinary metabolomic method based on gas chromatography-mass spectrometry (GC-MS) coupled with pattern recognition analysis was performed in three groups (control, model, and QHD group), to explore the effect of QHD on fatty liver and its mechanism of action. There was obvious separation between the model group and control group, and the QHD group showed a tendency of recovering to the control group in metabolic profiles. Twelve candidate biomarkers were identified and used to explore the possible mechanism. Then, a pathway analysis was performed using MetaboAnalyst 3.0 to illustrate the pathways of therapeutic action of QHD. QHD reversed the urinary metabolite abnormalities (tryptophan, uridine, and phenylalanine, etc.). Fatty liver might be prevented by QHD through regulating the dysfunctions of phenylalanine, tyrosine, and tryptophan biosynthesis, phenylalanine metabolism, and tryptophan metabolism. This work demonstrated that metabolomics might be helpful for understanding the mechanism of action of traditional Chinese medicine for future clinical evaluation.
机译:曲氏化瘀汤是一种重要的临床证明的草药配方,据报道可有效治疗高脂饮食诱导的大鼠脂肪肝。但是,尚未在代谢水平上阐明作用机理。在这项研究中,在三个组(对照组,模型组和QHD组)中,采用了基于气相色谱-质谱(GC-MS)结合模式识别分析的尿代谢组学方法,以探讨QHD对脂肪肝和肝硬化的影响。其作用机理。模型组与对照组之间有明显的分离,QHD组在代谢谱上显示出恢复到对照组的趋势。确定了十二种候选生物标记,并用于探索可能的机制。然后,使用MetaboAnalyst 3.0进行了途径分析,以阐明QHD的治疗作用途径。 QHD可逆转尿液代谢产物异常(色氨酸,尿苷和苯丙氨酸等)。 QHD可通过调节苯丙氨酸,酪氨酸和色氨酸生物合成,苯丙氨酸代谢和色氨酸代谢的功能障碍来预防脂肪肝。这项工作表明,代谢组学可能有助于理解中药的作用机理,以用于将来的临床评估。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号